Strategic Wealth Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$151K Sell
320
-1
-0.3% -$503 0.01% 335
2025
Q4
$150K Buy
321
+21
+7% +$9.75K 0.01% 354
2025
Q3
$128K Hold
300
0.01% 402
2025
Q2
$115K Buy
+300
New +$108K 0.01% 375
2019
Q4
Sell
-300
Closed -$35 282
2019
Q3
$35 Hold
300
﹤0.01% 320
2019
Q2
$40K Hold
300
0.02% 247
2019
Q1
$40K Hold
300
0.02% 257
2018
Q4
$39K Hold
300
0.02% 253
2018
Q3
$42K Hold
300
0.02% 240
2018
Q2
$31K Hold
300
0.02% 309
2018
Q1
$29K Hold
300
0.02% 303
2017
Q4
$24K Buy
+300
New +$24.1K 0.01% 302

Other funds holding HCA

Strategic Wealth Partners's HCA Position: Q1 2026 in Review

Strategic Wealth Partners reduced its HCA Healthcare (HCA) stake by 0.31% in Q1 2026, selling an estimated $503 and leaving 320 shares worth $151K. The position accounts for 0.01% of the portfolio, ranked #335.

Strategic Wealth Partners first reported a position in HCA in Q4 2017 and has held it in 12 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Strategic Wealth Partners held 320 shares of HCA Healthcare worth $151K as of Q1 2026.
  • Strategic Wealth Partners sold 1 HCA Healthcare share in Q1 2026, an estimated $503.
  • HCA Healthcare made up 0.01% of Strategic Wealth Partners's portfolio in Q1 2026, its #335 holding.
  • Strategic Wealth Partners first reported a position in HCA Healthcare in Q4 2017 and has held it in 12 quarters since.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Strategic Wealth Partners's 13F filing for Q1 2026, filed 12 May 2026.